ASST Spedali Civili Brescia
Brescia 25123
7 studies enrolling now · 11 studies all time
What they study most
Arthritis, Psoriatic, Chronic Lymphocytic Leukemia (CLL), Cutaneous Squamous Cell Carcinoma, Diffuse Large B Cell Lymphoma (DLBCL), Endometrial Cancer, Follicular Lymphoma (FL), Head and Neck Cancer, MF, Mantle Cell Lymphoma (MCL), Marginal Zone Lymphoma (MZL), Metastatic Head and Neck Cancer, Myelofibrosis
Studies at this site
- A Study to Evaluate TAR-210 Versus Intravesical Chemotherapy Treatment in Participants With High Risk Non-Muscle-Invasive Bladder Cancer — Recruiting now
- A Study to Evaluate the Efficacy and Safety of Icotrokinra (JNJ-77242113) in Biologic-experienced and Biologic-naive Participants With Active Psoriatic Arthritis — Recruiting now
- A Study to Assess the Safety and Efficacy of IPN10200 in Adult Participants With Upper Limb Spasticity. — Recruiting now
- A Clinical Trial Investigating the Safety, Tolerability, and Therapeutic Effects of BNT113 in Combination With Pembrolizumab Versus Pembrolizumab Alone for Patients With a Form of Head and Neck Cancer Positive for Human Papilloma Virus 16 and Expressing the Protein PD-L1 — Recruiting now
- Adjuvant Therapy in POLE-Mutated and p53-Wildtype/NSMP Early Stage Endometrial Cancer RAINBO BLUE & TAPER — Recruiting now
- A Study to Evaluate TAR-210 Versus Single Agent Intravesical Cancer Treatment in Participants With Bladder Cancer — Recruiting now
- A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies — Recruiting now
- Study of Navtemadlin add-on to Ruxolitinib in JAK Inhibitor-Naïve Patients With Myelofibrosis Who Have a Suboptimal Response to Ruxolitinib — Recruiting now
- A Study of Apalutamide in Participants With High-Risk, Localized or Locally Advanced Prostate Cancer Who Are Candidates for Radical Prostatectomy — Running, not enrolling
- Study of Adjuvant Cemiplimab Versus Placebo After Surgery and Radiation Therapy in Patients With High Risk Cutaneous Squamous Cell Carcinoma — Running, not enrolling
- The BURAN Study of Buparlisib in Patients With Recurrent or Metastatic HNSCC — Completed